Volume 18,Issue 12,2025 Table of Contents

   
Other Issues:  
  

本期目录

2025年 第12期 目录、封面、封底
  2025,18(12) [Abstract(157)]  [View PDF 5.20 M (281)]
  

述评

Hypertension management in chronic kidney disease: adherence to intensive blood pressure control and long-term time in target range
  ZHOU Shuwen1,2,3, CAI Guangyan2
  2025,18(12):1323-1327 [Abstract(188)]  [View PDF 432.72 K (417)]
  

慢性肾脏病防治专题

Precision medicine for IgA nephropathy: frontiers in epidemiology and pathogenesis
  ZHOU Ruijia, LIU Hong
  2025,18(12):1328-1335 [Abstract(187)]  [View PDF 551.00 K (367)]
  
Rho kinase signaling pathway mediates high uric acid-induced oxidative damage and apoptosis of renal tubular cells by regulating mitochondrial dynamin and biosynthesis related genes
  LI Jiachang1, MA Yuhan2, WEI Jiali1
  2025,18(12):1336-1341 [Abstract(174)]  [View PDF 1.42 M (364)]
  
Exploration on mechanism of action of nalfurafine in treatment of chronic kidney disease-associated pruritus based on network pharmacology and molecular docking techniques
  LI Jing, SHI Jingxuan, WANG Xu, ZHANG Zheng, ZHUO Li, LI Wenge
  2025,18(12):1342-1348 [Abstract(179)]  [View PDF 4.09 M (366)]
  
Artificial intelligence empowers kidney disease research: mechanism exploration and treatment optimization
  MENG Lingzhang1,2, YANG Mingyue1,2,3, XIONG Lijia1, WEI Suosu1, HUANG Xiaoyuan1, LIANG Huaqian1, MAO Xiuli1,2,4, ZHANG Xiamin1,2,4, LIN Wenxian1, YE Kun1
  2025,18(12):1349-1353 [Abstract(186)]  [View PDF 526.55 K (392)]
  
Analysis on the efficacy and safety of rituximab in treatment of refractory primary focal segmental glomerulosclerosis in adults
  GUAN Lisi1,2, YE Kun2,3, WEI Qiaoyu2,3, DENG Meiqiu2,3, HUANG Shaorong1,2
  2025,18(12):1354-1359 [Abstract(181)]  [View PDF 458.64 K (450)]
  

论著

Study on the role and molecular mechanism of HMGN1 in acute kidney injury based on the NLRP3 inflammatory pathway
  LUO Yuhan1, SHAO Xingqin1, ZHANG Lang1, XIE Ying2, YUAN Jing2, ZHA Yan2, LIN Xin2
  2025,18(12):1360-1365 [Abstract(164)]  [View PDF 2.44 M (293)]
  
Study on correlations of serum miR-27b-3p and miR-142-5p levels with disease progression of clear cell renal cell carcinoma and poor prognosis after retroperitoneal laparoscopic partial nephrectomy
  ZHANG Yuan, YAN Yuying, BIAN Yajin, WANG Xueying
  2025,18(12):1366-1371 [Abstract(161)]  [View PDF 828.27 K (288)]
  
Effects of HSA, IVIG and ATG infusions on blood transfusion compatibility testing
  TAI Shengfei, CHENG Tingting, XU Binglin, FU Lihui, MA Chunya, YU Yang
  2025,18(12):1372-1377 [Abstract(159)]  [View PDF 397.42 K (295)]
  
Analysis on associations of IL-17A, ICAM-1 and MUC5AC levels in bronchoalveolar lavage fluid and serum with MPP complicating AMP and clinical prognosis in pediatric patients
  LI Fang1, ZOU Deng1, LEI Chaolan1, PENG Xinxin2, LEI Yuan1
  2025,18(12):1378-1384 [Abstract(158)]  [View PDF 428.84 K (287)]
  
Analysis on application value of VITEK® 2 AST-YS08 card in drug sensitivity test of non-Candida albicans
  LIU Weimin1, XU Heping2, ZHENG Yanqing2, MA Xiaobo2
  2025,18(12):1385-1390 [Abstract(151)]  [View PDF 776.67 K (272)]
  
Analysis of plaque characteristics between small and large infarction lesions in the middle cerebral artery territory using 3.0T high-resolution vessel wall magnetic resonance imaging technology
  ZHANG Fengling1, ZHANG Ping1, ZHANG Yanli2, FU Yan2, YANG Dandan1, LIU Jiabao3
  2025,18(12):1391-1395 [Abstract(158)]  [View PDF 501.69 K (274)]
  
Observation on clinical efficacy of serplulimab in non-small cell lung cancer and its influence on T cell function
  YANG Xiuyuan, YU Lei
  2025,18(12):1396-1401 [Abstract(154)]  [View PDF 485.06 K (266)]
  
Observation on application effect of individualized treatments for ischemic stroke patients guided by the results of clopidogrel-related gene polymorphism and platelet aggregation tests
  LI Zhaoquan1, HUANG Jinshi1, LI Tao1, CHEN Yingdao2, CHEN Xiaoling2, WU Lifang1
  2025,18(12):1402-1407 [Abstract(156)]  [View PDF 829.61 K (287)]
  

病例报告

A case of primary squamous cell carcinoma of the breast
  WEN Xuzhi1, WU Puyuan2, ZHANG Qun2, ZHU Lijing2, QIAN Xiaoping2
  2025,18(12):1408-1411 [Abstract(164)]  [View PDF 1.10 M (314)]
  
A case of giant pulmonary bulla treated by percutaneous lung puncture combined with endoscopic cryoprecipitate instillation
  XIANG Na1,2, WEN Youli2, DENG Zhiping2
  2025,18(12):1412-1414 [Abstract(150)]  [View PDF 586.15 K (303)]
  

新进展综述

Research progress in complex immunopathogenesis and multi-target therapy of polymyositis
  MA Jingshu1, GAO Mengxun1, HU Maomao1, WANG Miaomiao1, MA Feilan1, GUO Donggeng1,2,3
  2025,18(12):1415-1419 [Abstract(152)]  [View PDF 452.96 K (297)]
  
Research progress of hyperthermic intraperitoneal chemotherapy combined with multimodal therapy in regulating the microenvironment of gynecological malignant tumors
  DUAN Shiqian1, YANG Jiang2, WEN Shiyu1, QIN Xiaomin2
  2025,18(12):1420-1424 [Abstract(148)]  [View PDF 413.50 K (277)]
  
Ethical dilemmas and governance paths of artificial intelligence in medical research and academic publishing
  JIANG Longyan, YU Jun, LYU Wenjuan, WEI Ying, ZHANG Hongman, HUANG Xiaohong
  2025,18(12):1425-1428 [Abstract(152)]  [View PDF 471.93 K (283)]
  

读者·作者·编者

Chinese Journal of New Clinical Medicine Vol. 18, 2025 general contents
  The Editorial Department of Chinese Journal of New Clinical Medicine
  2025,18(12) [Abstract(137)]  [View PDF 695.45 K (277)]